Cardiac ARrest : Brain OXymetry Depending on HYpothermia Depth
CARBOXHYD
Evaluation de l'oxymétrie cérébrale à Deux Niveaux d'Hypothermie thérapeutique après arrêt Cardiaque Extra-hospitalier
2 other identifiers
interventional
44
1 country
2
Brief Summary
Cardiac arrest is a major public health problem, with 700 000 cases per year , and a survival ranging from 4 to 33%. The post- anoxic encephalopathy remains the most serious complication with only a third of survivors . It is due to a series of phenomena involving microcirculation disorders . Cerebral oximetry is a new technique to evaluate the microcirculatory status . To this day it is used in cardiovascular surgery at risk of cerebral hypoperfusion where desaturation of cerebral oximetry is synonymous with ischemia and microcirculatory disorders. Therapeutic hypothermia is the only treatment improves the outcome of patients after extra- hospital cardiac arrest resuscitation . Its mechanisms of action seem to change all the phenomena responsible for microcirculatory reperfusion disorders . Currently it is recommended to practice hypothermia between 32 and 34 ° C. However, a recent study suggests a superiority of hypothermia at 32 ° C rather than 34 ° C. The hypothesis of this study is that cerebral oximetry value will be different in patients subjected to two different levels of therapeutic hypothermia in the aftermath of an extra- hospital cardiac arrest. These data allow a better understanding of the mechanisms underlying the benefit of this technique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2014
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 20, 2013
CompletedFirst Posted
Study publicly available on registry
February 3, 2014
CompletedStudy Start
First participant enrolled
March 28, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 9, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 9, 2017
CompletedMarch 22, 2023
August 1, 2018
3 years
November 20, 2013
March 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mesure of cerebral oximetry
During the first 48 hours of hospitalization, we will collect the cerebral oximetry values in the two cerebral hemispheres.
8 times during the first 48 hours of hospitalization
Secondary Outcomes (4)
The cerebral oximetry values (average of the two hemispheres) will be compared between patients with good and poor neurological outcome.
8 times during the first 48 hours of hospitalization
For each level of therapeutic hypothermia the cerebral oximetry values will be compared between patients with good and poor becoming
baseline, when target temperature is reached, 6 hours, 12 hours, 18 hours, 24 hours, when 37°C is reached
Outcome of patients
6 months after hospitalization
Mesure of lactate
4 times during the first 48 hours of hospitalization
Study Arms (2)
34°C
EXPERIMENTALtherapeutic hypothermia at 34 ° C
32°C
EXPERIMENTALtherapeutic hypothermia at 32 ° C
Interventions
Eligibility Criteria
You may qualify if:
- Patient presented with an extra-hospital cardiac arrest resuscitation and to benefit from therapeutic hypothermia using a servo system to its temperature (CoolGard 3000 ® system)
- Age\> 18 years and \<80 years
You may not qualify if:
- Major Patient protected by law
- Private person administrative or judicial freedom
- Neurological or traumatic cause of cardiac arrest
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
CH de Fréjus-Saint Raphael
Fréjus, 83608, France
CHU de Nice - Hôpital Saint Roch
Nice, 06000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jean-Christophe ORBAN, MD
Centre Hospitalier Universitaire de Nice
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 20, 2013
First Posted
February 3, 2014
Study Start
March 28, 2014
Primary Completion
March 9, 2017
Study Completion
March 9, 2017
Last Updated
March 22, 2023
Record last verified: 2018-08